Stock 4151 KYOWA KIRIN CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Kyowa Kirin Co. Ltd.

Equities

4151

JP3256000005

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-16 am EDT 		5-day change 1st Jan Change
2,657 JPY -0.47% Intraday chart for Kyowa Kirin Co. Ltd. +1.01% +12.11%
Apr. 08 U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease RE
Apr. 03 Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ (istradefylline) and Other Parkinson's Disease Add-On Therapies
AQ
First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome
BU
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease
RE
Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March
MT
Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.
CI
Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed
MT
Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation
MT
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag
RE
US approves first gene therapy for children with rare genetic disease
RE
US approves first gene therapy for rare genetic disease
RE
Kyowa Kirin Will Present Phase 2b Post-hoc Analysis and Symposium at the American Academy of Dermatology Annual Meeting 2024
AQ
Kyowa Kirin Co., Ltd. to Present Phase 2B Post-Hoc Analysis and Symposium At the American Academy of Dermatology Annual Meeting 2024
CI
Kyowa Kirin : Partial Corrections to “Notice of Convocation of the 101st Ordinary General Meeting of Shareholders” (0B)
PU
Kyowa Kirin Buys Back Nearly 3 Billion Yen of Shares
MT
China Deflation, Bank of Japan Roil Asian Stock Markets
MT
Japan's Nikkei closes at 34-year peak on dovish BOJ; tech shares soar
RE
Japan's Nikkei leaps to 2-week high on tech stocks, yen boost
RE
BridgeBio Pharma Unit to Grant Kyowa Kirin License for Infigratinib in Japan
MT
Kyowa Kirin's Profit Up 52% in Fiscal 2023
MT
Kyowa Kirin Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4151 Stock
  4. News Kyowa Kirin Co. Ltd.